{"version":"1.0","type":"link","title":"Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy.","author_name":"Dong Z 외","author_url":"https://prs-insight.online/author/Dong%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/107399","thumbnail_width":1200,"thumbnail_height":630}